Oak Ridge Investments LLC Prothena Corp Public LTD CO Transaction History

Oak Ridge Investments LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2018 Aug 13, 2018	SELL	$10.99 - $44.21 $1.56 Million - $6.29 Million	-142,351 Closed	0 $0
Q1 2018 May 14, 2018	SELL	$27.95 - $45.04 $1.06 Million - $1.71 Million	-37,910 Reduced 21.03%	142,351 $5.23 Million
Q4 2017 Feb 13, 2018	SELL	$35.44 - $63.76 $3.81 Million - $6.85 Million	-107,395 Reduced 37.33%	180,261 $6.76 Million
Q3 2017 Nov 07, 2017	SELL	$53.83 - $67.75 $6.34 Million - $7.98 Million	-117,720 Reduced 29.04%	287,656 $18.6 Million
Q2 2017 Aug 10, 2017	BUY	N/A	405,376	405,376 $21.9 Million

184

42.7M

162K

102K

Ticker PRTA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 46,922,800
Market Cap $714M
Description
Prothena Corporation plc, a late-stage clinical company, focuses on discovery and development of novel therapies for life-threatening diseases in the United States. The company is involved in developing Birtamimab, an investigational humanized antibody that is in Phase III clinical trial for the treatment of AL amyloidosis; Prasinezumab, a human...

Get notified when there are updates to the investment portfolio of Oak Ridge Investments LLC, based on Form 13F filings with the SEC.

Stay updated on Oak Ridge Investments LLC with notifications on news.